The Absolute Oral Bioavailability and Population-Based Pharmacokinetic Modelling of a Novel Dipeptidylpeptidase-IV Inhibitor, Vildagliptin, in Healthy Volunteers

Author: He Yan-Ling  

Publisher: Adis International

ISSN: 0312-5963

Source: Clinical Pharmacokinetics, Vol.46, Iss.9, 2007-01, pp. : 787-802

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content